These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7008568)

  • 1. Extra-adrenergic mechanisms responsible for the effects of glucose-insulin-potassium solution on vulnerability to ventricular fibrillation.
    Brooks WW; Verrier RL; Lown B
    Am J Cardiol; 1981 Feb; 47(2):251-7. PubMed ID: 7008568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.
    Brooks WW; Verrier RL; Lown B
    Cardiovasc Res; 1980 May; 14(5):295-302. PubMed ID: 7388861
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of sulfinpyrazone on ventricular vulnerability in the normal and the ischemic heart.
    Raeder EA; Verrier RL; Lown B
    Am J Cardiol; 1982 Aug; 50(2):271-5. PubMed ID: 7102558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of hypokalemia on susceptibility to ventricular fibrillation in the normal and ischemic canine heart.
    Hohnloser SH; Verrier RL; Lown B; Raeder EA
    Am Heart J; 1986 Jul; 112(1):32-5. PubMed ID: 3728285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines.
    Liang C; Doherty JU; Faillace R; Maekawa K; Arnold S; Gavras H; Hood WB
    J Clin Invest; 1982 Jun; 69(6):1321-36. PubMed ID: 6123523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Lombardi F; Verrier RL; Lown B
    Am Heart J; 1983 Jun; 105(6):958-65. PubMed ID: 6858844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion.
    Kliks BR; Burgess MJ; Abildskov JA
    Am J Cardiol; 1975 Jul; 36(1):45-9. PubMed ID: 1146697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of clonidine on vulnerability to fibrillation in the normal and ischemic canine ventricle.
    Rotenberg FA; Verrier RL; Lown B; Sole MJ
    Eur J Pharmacol; 1978 Jan; 47(1):71-9. PubMed ID: 618732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
    Stockman MB; Verrier RL; Lown B
    Am J Cardiol; 1979 Feb; 43(2):233-8. PubMed ID: 104608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of adrenergic and muscarinic receptor stimulation on serum potassium concentrations and myocardial electrical stability.
    Hohnloser SH; Verrier RL; Lown B
    Cardiovasc Res; 1986 Dec; 20(12):891-6. PubMed ID: 2879627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin and beta adrenergic effects during endotoxin shock: in vivo myocardial interactions.
    Law WR; McLane MP; Raymond RM
    Cardiovasc Res; 1990 Jan; 24(1):72-80. PubMed ID: 2183937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pretreatment with propranolol on potassium, calcium, and magnesium shifts after ventricular fibrillation in dogs.
    Salerno DM; Murakami M; Elsperger KJ
    J Lab Clin Med; 1989 Nov; 114(5):595-603. PubMed ID: 2809400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glucose-insulin-potassium solution on free fatty acid metabolism in ischemic myocardium.
    Kobayashi A; Kamiya J; Yamashita T; Ishizaka K; Hayashi H; Kamikawa T; Yamazaki N
    Jpn Circ J; 1984 Jun; 48(6):591-5. PubMed ID: 6376844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Protective effect of glucose-insulin-potassium solutions in myocardial damage caused by emetine].
    de Micheli A; Medrano GA; Villarreal A; Sodi-Pallares D
    Arch Inst Cardiol Mex; 1975; 45(4):469-86. PubMed ID: 1101837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Norepinephrine release by ventricular stimulation: effect on fibrillation thresholds.
    Euler DE
    Am J Physiol; 1980 Mar; 238(3):H406-13. PubMed ID: 7369386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of excitability on the ventricular fibrillation threshold in dogs.
    Gaum WE; Elharrar V; Walker PD; Zipes DP
    Am J Cardiol; 1977 Dec; 40(6):929-35. PubMed ID: 930840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of glucose-insulin-potassium on thallium-201 myocardial redistribution.
    Wilson RA; Okada RD; Barlai-Kovach M; Strauss HW
    Int J Nucl Med Biol; 1985; 12(2):97-101. PubMed ID: 3899963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.
    Corbalan R; Verrier RL; Lown B
    Am Heart J; 1976 Aug; 92(2):223-30. PubMed ID: 941834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of glucose, insulin, and potassium on vulnerability to ventricular fibrillation in the canine heart.
    Obeid AI; Verrier RL; Lown B
    Circ Res; 1978 Oct; 43(4):601-8. PubMed ID: 688560
    [No Abstract]   [Full Text] [Related]  

  • 20. Repetitive extrasystole as an index of vulnerability to ventricular fibrillation.
    Matta RJ; Verrier RL; Lown B
    Am J Physiol; 1976 Jun; 230(6):1469-73. PubMed ID: 59552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.